NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5

Selina Gurri1, Beat Siegenthaler1, Michael Cangkrama1

  • 1Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.

EMBO Molecular Medicine
|October 9, 2023
PubMed

Insights

The transcription factor NRF3 acts as a skin tumor suppressor. Its absence promotes skin cancer progression by increasing HSPA5 levels, suggesting HSPA5 inhibition as a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Epithelial skin cancers are prevalent, yet the mechanisms driving their malignancy remain unclear.
  • Understanding these mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To identify novel tumor suppressors in skin cancer.
  • To elucidate the molecular mechanisms of skin cancer progression.
  • To explore potential therapeutic targets for epithelial skin cancers.

Main Methods:

  • Investigated NRF3 (Nuclear factor erythroid 2-related factor 3) expression in patient-derived basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) samples.
  • Utilized mouse models to assess the role of NRF3 deficiency in skin tumor development and progression.
  • Performed in vitro assays (clonogenic growth, migration, 3D invasion) with human SCC cells.
  • Identified and validated NRF3 interactors using co-immunoprecipitation and Western blotting.
  • Assessed the impact of HSPA5 (Heat shock protein family A member 5) modulation on cancer cell phenotypes and tumor growth.
  • Evaluated the efficacy of HSPA5 inhibition in preclinical models.

Main Results:

  • NRF3 protein expression was significantly downregulated in invasive BCC and SCC cells.
  • NRF3 deficiency promoted skin tumor malignant conversion, enhanced SCC cell clonogenicity, migration, and invasiveness.
  • NRF3 deficiency led to increased HSPA5 levels, which promoted cancer cell survival and migration.
  • Pharmacological inhibition or knockdown of HSPA5 reversed the malignant phenotypes of NRF3-deficient SCC cells in vitro and in vivo.
  • High HSPA5 expression correlated with NRF3 deficiency in patient SCC samples.

Conclusions:

  • NRF3 functions as a tumor suppressor in epithelial skin cancers.
  • The NRF3-HSPA5 axis is a critical regulator of skin cancer progression.
  • Targeting HSPA5 represents a promising therapeutic strategy for NRF3-deficient skin cancers.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K